Switch to:
Biomarin Pharmaceutical Inc (NAS:BMRN)
EV/EBIT
-150.06 (As of Today)

EV/EBIT ratio is calculated as enterprise value divided by its EBIT. As of today, Biomarin Pharmaceutical Inc's enterprise value is $13,170.7 Mil. Biomarin Pharmaceutical Inc's operating income for the trailing twelve months (TTM) ended in Sep. 2014 was $-86.4 Mil. Therefore, Biomarin Pharmaceutical Inc's EV/EBIT ratio for today is -150.06.

BMRN' s 10-Year EV/EBIT Range
Min: -1750.3   Max: 67133.8
Current: -150.06

-1750.3
67133.8

During the past 13 years, the highest EV/EBIT Ratio of Biomarin Pharmaceutical Inc was 67133.80. The lowest was -1750.30. And the median was -40.40.

BMRN's EV/EBITis ranked higher than
78% of the 1323 Companies
in the Global Biotechnology industry.

( Industry Median: 9999.00 vs. BMRN: -150.06 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt). Biomarin Pharmaceutical Inc's enterprise value for the quarter that ended in Sep. 2014 was $10,752.9 Mil. Biomarin Pharmaceutical Inc's Operating Income for the trailing twelve months (TTM) ended in Sep. 2014 was $-86.4 Mil. Biomarin Pharmaceutical Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2014 was -0.80%.


Definition

Biomarin Pharmaceutical Inc's EV/EBIT for today is calculated as:

EV/EBIT=Enterprise Value (Today)/Operating Income (TTM)
=13170.711/-86.445
=-152.36

Biomarin Pharmaceutical Inc's current Enterprise Value is $13,170.7 Mil.
Biomarin Pharmaceutical Inc's Operating Income for the trailing twelve months (TTM) ended in Sep. 2014 was -52.31 (Dec. 2013 ) + -26.456 (Mar. 2014 ) + -18.882 (Jun. 2014 ) + 11.203 (Sep. 2014 ) = $-86.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt).

Biomarin Pharmaceutical Inc's Earnings Yield (Joel Greenblatt) for the quarter that ended in Sep. 2014 is calculated as:

Earnings Yield (Joel Greenblatt) (Q: Sep. 2014 )=Operating Income (TTM)/Enterprise Value (Q: Sep. 2014 )
=-86.445/10752.901
=-0.80 %

Biomarin Pharmaceutical Inc's Enterprise Value for the quarter that ended in Sep. 2014 was $10,752.9 Mil.
Biomarin Pharmaceutical Inc's Operating Income for the trailing twelve months (TTM) ended in Sep. 2014 was -52.31 (Dec. 2013 ) + -26.456 (Mar. 2014 ) + -18.882 (Jun. 2014 ) + 11.203 (Sep. 2014 ) = $-86.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Related Terms

Enterprise Value, Operating Income, Earnings Yield (Joel Greenblatt)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Biomarin Pharmaceutical Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebit -3.54-14.06-58.32-58.4043.12127.565,666.68-120.97-55.23-63.86

Biomarin Pharmaceutical Inc Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebit -53.73-57.89-55.23-66.56-68.10-66.14-63.86-64.96-61.03-124.39
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK